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Summary
Purpose of the study: Desmoid-type ﬁbromatosis is a ﬁbroblastic proliferation that develops in
the deep soft tissues and is characterized by inﬁltrative growth and a tendency towards local
recurrence but does not metastasize. Fibromatosis of the chest wall is rare, representing only
10 to 20% of all deep ﬁbromatoses.
Case report: We report a six cases series of ﬁbromatosis of the chest wall treated at our insti-
tution between 1996 and 2009. There were ﬁve men and one woman with a mean age of 42.2.
Swelling of the chest wall was the most frequent symptom. Imaging showed an expansive homo-
geneous mass, invading the rib (four cases) or the sternum (two cases). Surgical resection was
performed in all cases. The outcome was favorable (ﬁve cases) or marked by local recurrence
(one case).
Discussion: Although it is considered to be a benign lesion, this tumor can be locally very aggres-
sive, and has a high local recurrence rate depending upon the efﬁcacy of surgical resection.
r Ma© 2010 Published by Elsevientroduction
esmoid-type ﬁbromatoses of the deep tissue are rare soft
issue tumors characterized by proliferation of ﬁbroblast
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nd myoﬁbroblast-type spindle cells, which inﬁltrate muscu-
oaponeurotic tissue. They represent 3.5% of ﬁbrous tumors
nd 0.03% of all neoplasms [1]. Although they are considered
o be benign tumors, they can be very aggressive locally with
high risk of local recurrence after surgical excision, but do
ot metastasize [2]. Although the etiology of these tumors
s unknown, certain factors play a role in their development
nd growth. There is no generally accepted protocol for
reatment. Nevertheless extremely thorough surgical resec-
ion is essential. Radiotherapy can be beneﬁcial in case
.
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of residual or inoperable tumors. These tumors are usually
found in the abdomen. [3]. Fibromatoses of the chest wall
are rare and only represent 10 to 20% of all ﬁbromatoses
[1,4].
We report a series of six cases of ﬁbromatoses of the chest
wall treated by surgical resection and discuss the anatomo-
clinical features of this tumor as well as the main differential
diagnoses.
Observations
This is a retrospective study of six cases of ﬁbromato-
sis of the chest wall that were surgically treated at our
institution between January 1, 1996 and December 31,
2009 (Table 1). All patients underwent a complete clinical
examination, chest X-ray and CT Scan. Magnetic resonance
imaging (MRI) was only performed in one patient. Surgi-
cal samples were obtained of all tumors. The age and sex
of patients, the tumor location and symptoms as well as
the radiological features, ﬁnal histology, treatment and out-
come were recorded. The results are presented in Table 1.
Samples were ﬁxed in formol then embedded in parafﬁn. Tis-
sue samples were cut into four-micron pieces stained with
hematoxyline-eosine and examined on conventional optic
microscopy. An immunohistochemical study was performed
in all cases. A panel of antibodies was used associating
alpha smooth muscle actin, desmin, PS100, CD34, EMA,
cytokeratin and vimentin. The streptavidin biotin peroxi-
dase complex immunohistochemical technique was used.
Age/gender
The mean age of patients was 42.2 years old with a range of
15 to 67. Half of the patient population was under 40 (three
cases). There were ﬁve men and one woman (sex-ratio 5).
Medical History
One patient had a history of chest trauma, one year before.
Two patients had a history of surgery: coronary artery bypass
surgery 7 years before in one patient and a pulmonary
hydatid cyst 18 months before the diagnosis of the ﬁbro-
matosis in the other.
Clinical picture
A progressively expanding swelling in the chest wall was
the reason for consulting in all patients. Swelling was iso-
lated in three of these patients. Symptoms of neurovascular
compression such as pain and paresthesia were found in
one patient. Respiratory symptoms including lower chest
pain, coughing and dyspnea were found in one patient. Two
patients were in poor general condition. On clinical exam-
ination, the swelling in the chest was usually ﬁrm, poorly
circumscribed, non inﬂammatory, attached to the deep tis-
sues and sometimes painful. The location was the anterior
lower thorax (two cases), parasternal (two cases), pectoral
(one case) or dorsal (one case).
r
b
a
S
5103
dditional tests
iological tests were normal in all patients. Chest X-ray
howed an opaque image eroding the adjacent bone tis-
ue in ﬁve cases. It was normal in the 6th case. Chest CT
can showed a homogenous, enlarging mass with lack of
nhancement after contrast injection, which was invading
he soft tissue but left the pulmonary parenchyma intact.
he tumor had invaded the ribs in ﬁve cases (Figs. 1 and 2),
ncluding one case with invasion of the sternum (Fig. 3).
nvasion of the sternum alone was noted in one case. Chest
RI was indicated in one patient to evaluate tumor invasion
n neighboring structures, in particular vascular structures.
t showed a highly vascularized tumor without vascular inva-
ion. Because of the radiological features showing tumor
ggressivity a malignant sarcoma-type tumor was highly
uspected. A transparietal biopsy was performed before sur-
ical resection in three cases, suggesting the diagnosis in two
ases.
reatment
ll cases were treated surgically. Wide resection with a
umor free margin (> 2 cm) was performed. It was complete
n all cases. Resection was extended to include the sternum
n two cases and the ribs in ﬁve cases. Between one and four
ibs were resected. The post-operative course was simple in
ll cases.
istological study
acroscopic examination showed a yellowish or pink tumor,
hich was often poorly circumscribed, ﬁrm and fasciculated
hen cut. The size varied from 7 to 11.5 cm, the mean
ize was 8.75 cm. Histological examination showed a tumor
ith a proliferation of ﬁbroblastic and myoﬁbroblastic-type
pindle cells arranged in parallel bundles, with variable cel-
ularity, in the presence of mixoid and edematous areas,
oexisting with areas of higher cellular density (Fig. 4).
hese tumor bundles were intersected by bands of hyalin-
zed collagen. The poorly circumscribed tumor had invaded
he soft tissues. On immunohistochemical study the tumor
ells were positive for alpha smooth muscle actin and
imentin (Fig. 4). The histological study also conﬁrmed
umoral invasion of the rib or sternum in all cases (Fig. 5). In
wo cases in which resection was considered to be complete
uring surgery, microscopic examination revealed tumoral
egments or adhesions (cases no. 2 and 5).
utcome, progression
atients were followed up for between 8 months and 6 years
ith a mean follow-up of 3 years. The outcome was favor-
ble in ﬁve cases and resulted in recurrence in one case in
hich resection was shown to be incomplete. In this patient
ecurrence was diagnosed at 2 years of follow-up revealed
y a voluminous tumor of 11× 7 cm, which reached the 5th
nd 6th rib and invaded the right lower lobe of the lung.
urgical resection included a tumorectomy, resection of the
th and 6th ribs as well as of the posterior arches of the 7th
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Table 1 Features of six cases of ﬁbromatosis of the chest wall.
Case Sex/age
(years)
Location History Clinical Imaging Size (cm) Surgery Follow-up Progression
1 M/32 7th, 8th, 9th
and 10th left
ribs
NA Left anterior lower
chest
Well-circumscribed
homogenous tumor no contrast
enhancement no visceral
invasion
10 Complete 5 years Stable
2 W/55 8th and9th
right ribs
Chest trauma Solid attached poorly
circumscribed tumor
of the right lower
chest. Lower chest
pain dyspnea cough
PGC
Rib lysis with opacity of the
external parietal pleura and
endothoracic extension into
the soft tissues
10 Complete 6 years 2 cases of
recurrence
3 M/67 Sternum, 2nd
and 3rd ribs
Coronary artery
bypass
Hard parasternal
tumor of the chest
attached to the
chondrosternal joint
of the 2nd rib.
Dysphonic-PGC
Aggressive tumor invading the
chest wall and the anterior
mediastinis, in contact with
the ascending aorta
7 Complete 18 months Stable
4 M/45 2nd right rib NA Tumor in the right
pectoral region.
Painful-
neurovascular
symptoms
(paresthesia)
Tumor expanding into the ribs
with areas of peripheral
osteocondensation and cortical
narrowing with no signs of
muscular or pulmonary invasion
7 Complete 4 years Stable
5 M/15 Sternum soft
tissues
NA Tumor of the inferior
end of the sternum
Vascularized mass of tissue
centered upon the xyphoid
apophysis invading the large
right muscle of the sternal
bone
7 Complete 2 years Stable
6 M/39 5th rib Surgery for a
hydatic cyst of
the lower left
lobe
Dorsal tumor on a
scar from a posterior
thoracotomy
Deep parietal submuscular
tumor across from the surgical
site slight peripheral
enhancement with contrast
medium
11.5 Complete 8 months Stable
M: man; W: woman; NA: not applicable; PGC: poor general condition.
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Figure 1 CT Scan of the chest with a mediastinal window with
contrast injection (case no. 1): tumor of the chest wall, well cir-
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rcumscribed, homogenous, lacking enhancement after contrast
injection with lysis of the arc of the 7th and 8th left ribs.
and 8th ribs, atypical resection of the right lower lobe of
the lung and a tissue sample of the parietal pleura. Histo-
logical analysis conﬁrmed recurrence and pleuropulmonary
invasion. Radiotherapy was indicated but the patient was
lost-to-follow-up. She consulted 2 years later for a second
case of recurrence. This included a 2 cm tumoral nodule of
the main axis located on the posterior 5th rib stump extend-
ing to the 4th rib and another 1 cm nodule attached to the
pulmonary parenchyma. Surgical resection was complete,
conﬁrmed microscopically on rib samples.
Figure 2 CT Scan of the chest with a mediastinal window
after contrast injection (case no. 6): posterior chest wall tumor
(arrow) well circumscribed, dense tissue, homogenous, with no
enhancement, without lysis of the adjacent rib.
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migure 3 CT Scan of the chest with a mediastinal window and
ontrast injection (case no. 3): parasternal tumor with chest
all and endothoracic invasion.
iscussion
esmoid-type tumors, which were previously called deep
bromatoses, were ﬁrst described in the abdominal wall
y Mac Farlane in 1832 [1]. Extra-abdominal types were
escribed later, in particular in the limbs and the scapular
elt [5]. Tumors in the chest wall have only been reported
n 10 to 20% of cases, while intrathoracic locations are
are. [1,4]. These extra-abdominal types, which are more
enerally called aggressive ﬁbromatoses, are generally dis-
inguished by their deep location, and slow progressive
rowth, without metastases but with a high risk of local
nvasion and post-operative recurrence [5]. These tumors
evelop on the conjunctive tissue, fascias, aponeuroses or
igure 4 Histology (HE ×400): spindle cell proliferation if par-
llel bundles intersected with collagen bands. In the lower right
mage, tumor cells are seen to be positive for alpha smooth
uscle actin (IHC ×400).
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radiotherapy and surgery, especially in children, and thisigure 5 Histology (HE ×100): ﬁbromatosis with invasion of
one trabeculae.
ntramuscular compartments [6]. Although the pathogenic
echanism of these tumors has not been clearly elucidated,
ifferent factors seem to play a role. The role of hormones
as been suggested, with the inﬂuence of estrogens and
heir antagonists such as tomoxifen, on tumor growth [6,7].
ertain traumas also seem to play a role in the develop-
ent of these tumors. Indeed, they can develop in contact
ith breast implants on the muscles transposed for recon-
truction, on surgical throacotomy scars or even after simple
ntramuscular injections. [7,8]. In our series two cases of
bromatosis developed on a surgical thoracotomy scar and
n one case it was post-traumatic. The delay between chest
urgery and the development of the tumor was 18 months
nd 7 years respectively. In 15% of cases, ﬁbromatosis was
ssociated with familial polyadenomatosis and was a sign
f Garnder syndrome [7]. Certain authors have identiﬁed
deletion of the long arm of chromosome 5 in case of
he association of desmoid tumor-Gardner syndrome [6].
n a series of 53 cases of ﬁbromatosis of the chest wall
eported by Abbas et al, the mean age at diagnosis was 39
ith a range between 10 and 78. There were slightly more
omen than men in most studies [9,10]. Fibromatosis of the
hest wall usually presents in the form of a tumor of var-
ous sizes but which is often large. In the literature, the
ize of tumors varies from 5 to 10 cm and is rarely larger
han 20 cm. In the series by Kabiri et al, tumor size var-
ed from 2 to 13 cm with a mean of 6 cm [4]. In our series,
he average tumor was 8.75 cm. The tumor was attached
o deep tissue, ﬁrm and painless in most cases. It only
ecomes symptomatic due to mechanical compression of
eighboring organs [9,11]. In case of invasion of the ner-
ous structures, hyperesthesia, muscular weakness or more
arely pain may develop. In our series neurovascular symp-
oms such as paresthesia and pain were noted in one case.
hest X-ray shows a parietal tumor that has invaded the
oft tissues, the adjacent bone tissue, and in certain cases
he nearby periosteum [9]. Ultrasound can reveal abnor-
al but nonspeciﬁc echogenicity [6]. CT Scan can be used
o identify the location and size of the tumor. When ﬁbro-
atosis is in contact with bone, reaction of the adjacent
t
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one varies, but is mainly a spiculated periosteal reaction
s well as erosion or even cortical destruction. CT-guided
iopsies can sometimes be performed, suggesting a diagno-
is in certain cases [12]. Nevertheless, MRI is more sensitive
han CT Scan for evaluating bone invasion when the tumor
s in contact with bone [5,12]. It can also be used to mon-
tor lesions after treatment. Classically, the characteristics
f ﬁbromatosis on MRI include a poorly circumscribed het-
rogenous tumor, with an isosignal on T1 and a high intensity
ignal on T2 weighted sequences (when the cellular com-
onent is predominant) as well as contrast enhancement
f internal septa and a low intensity signal of the pseu-
ocapsule in all sequences. Well-circumscribed lesions and
ow intensity signal T1 and T2 weighted sequences with-
ut contrast enhancement have also been described when
he ﬁbrous component is predominant. These radiological
eatures are fairly similar to those of soft tissue malignant
umors: heterogenous signal, poorly circumscribed lesions,
2 weighted high intensity signal, as well as neurovascular
r bone invasion. Indeed, low-grade sarcoma is impossible
o differentiate from desmoid ﬁbromatosis on imaging and it
s therefore the major differential diagnosis [12]. The ﬁnal
iagnosis is histopathological. An initial CT-guided biopsy
f the parietal pleura should probably be performed if the
esion is inaccessible in particular to make certain differen-
ial diagnoses, which may require primary chemotherapy. On
esected tumor samples, the tumor is ﬁrm, poorly circum-
cribed and appears fasciculated when cut. Histologically,
here is a proliferation of ﬁbroblast and myoﬁbroblast-
ike spindle cells arranged in parallel bundles, intersected
y more or less thick ‘‘cheloid-type’’ hyalinized collagen
ands. Atypical nuclei and mitoses are rare. The poorly cir-
umscribed tumor invades the soft tissues [10]. There is no
hondrogenesis or osteogenesis. On immunohistochemistry,
he spindle cells express alpha smooth muscle actin and
imentin. They are PS100, CD34 and keratin negative. A dif-
erential diagnosis must be made from well-differentiated
brosarcoma, which can mainly be excluded in the absence
f ﬁbroblasts with large hyperchromatic, mitotic nuclei
n less abundant stromal collagen. There is no generally
ccepted treatment protocol. Nevertheless, patient man-
gement should be multidisciplinary to prevent the high risk
f recurrence [6]. Surgical treatment includes the widest
ossible resection, which is often complicated. However,
arcinological resection without mutilation is often difﬁcult
ecause of the large sized and poorly circumscribed tumor as
ell as its proximity to vital structures such as the brachial
lexus or bone marrow [2,13]. Local recurrence is frequent
nd can occur after several operations [5]. Indeed, on the
hest wall, besides obtaining a wide tumor free margin,
esection of the ribs above and below should be performed
ith a 2 to 4 cm margin [7,10]. Another therapeutic alter-
ative includes high doses of radiotherapy associated with
urgical treatment. Radiotherapy is beneﬁcial in case of a
esidual tumor or inoperable locations, and results in recur-
ence free survival in 77% of cases [14]. Nevertheless there
re still potential complications associated with combinedreatment not satisfactory [5]. Medical treatment has been
ttempted when surgery is unsuccessful. Treatment with
ytotoxic as well as non-cytotoxic chemotherapies has been
eported: hormonal, non-steroid anti-inﬂammatories, and
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interferon  [5]. Nevertheless, the progression of desmoid
ﬁbromatosis is unpredictable. Spontaneous regression has
been described in the absence of any treatment or with
partial resection, as has tumoral stabilization but also sar-
comatous degeneration [6]. Recurrence occurs in 25 to 75%
of cases in the chest wall depending on the series [9,15].
Although survival at 5 years is nearly 93%, the probability of
recurrence after 5 years is an estimated 29% [11,16]. Even
though these tumors do not metastasize, they can result in
signiﬁcant morbidity and death from locoregional invasion
[17].
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